SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)

$10.01 0.74 (7.9827%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 58

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) News Sources

Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition

08-12-2025

yahoo.com

Is Sumitomo Pharma’s 344% 2025 Surge Still Supported by Its Fundamentals?

10-12-2025

yahoo.com

Bank of Japan Outlook, Beijing Economic Report Roil Asian Stock Markets

29-12-2025

yahoo.com

Sumitomo Chemical Co Ltd (SOMMF) (Q1 2027) Earnings Call Highlights: Core Operating Income ...

04-08-2026

yahoo.com

Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa

12-08-2026

yahoo.com

Non-Metastatic Prostate Cancer Market to Exhibit Growth at a CAGR of 4% During the Forecast Period (2026-2036), as Pharmaceutical Companies Intensify Development of Advanced Therapies | DelveInsight

18-08-2026

yahoo.com

Interest Rate, Oil, Tech Jitters Blunt Asian Stock Markets

02-09-2026

yahoo.com

Sumitomo Pharma (TSE:4506) Stock Looks Below Fair Value On Earnings Power

04-09-2026

yahoo.com

2026 Assessment of the Nuvisertib Market: Sales Forecasts, Clinical Differentiation, Competitive Threats, and Commercial Opportunities Through 2034

10-09-2026

yahoo.com

Slate Medicines Names Kenneth Koblan as Chief Scientific Officer

15-09-2026

yahoo.com

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) Sentiment Trend

0 25 50 75 100 72 82 14 80 55 75 5 51 75 68 08-12-2025 10-12-2025 29-12-2025 04-08-2026 12-08-2026 18-08-2026 02-09-2026 04-09-2026 10-09-2026 15-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) FAQs

toggle

What is the current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is $10.01.


toggle

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is $0.74.


toggle

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is 7.9827%.


toggle

What is the most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is 58 out of 100.


toggle

What is the most recent average sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The most recent sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is .


SEC-8K** Filing Available For SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.